dotMD.com
Join Community
📖Clinical Research Library Talk in Sleep, Anxiety & Focus Space 711+ Logs • Free →🧮Lab Calculator ↓
Reading this clinical breakthrough? See how real patients are applying these numbers in real life. See what actually stopped 3 AM wakeups, racing thoughts, and morning grogginess—100% free with a private @handle and zero login wall.
Click to Ask a Question or Post Your Experience ▾
Post to Sleep, Anxiety & Focus Space (15 Seconds • No Account or Email Required)
Or read existing discussions in Sleep, Anxiety & Focus Space →
★ Breakthrough Medical Research • 15 Landmark Multi-Trial Guides • 6,255 Indexed Studies

Sleep Architecture, Anxiety, Depression & Brain Health — Clinical Trial Breakdowns & PubMed Evidence

Double-blind RCTs on Magnesium Bisglycinate NMDA/GABA receptor modulation and nocturnal cortisol reduction, antidepressant remission meta-analyses, SAMe augmentation trials, and optical smartwatch HRV validation studies. Explore 673 indexed studies and multi-trial syntheses with verified PubMed PMIDs, participant sample sizes (N), and Absolute vs. Relative Risk numbers.

★ #1 Lead Breakthrough Study • NEJM SURMOUNT-1 (176 Weeks) N = 1,032 Adults • p < 0.001

Once-Weekly Tirzepatide Cuts Type 2 Diabetes Progression by 94% Over 3 Years—With a 22.9% Sustained Weight Reduction

The Plain-English Receipt: Only 1.2% of prediabetic adults on Tirzepatide progressed to Type 2 diabetes over 3.4 years vs. 19.3% on placebo (Absolute Risk Reduction = 18.1% • Number Needed to Treat = 6).

Read the Full Breakthrough Breakdown → Jump to All 15 Landmark Breakthroughs ↓
Two biomedical scientists in white lab coats inside a sunlit medical research laboratory pipetting clinical assay samples and reviewing trial results
Inside the Clinical Evidence Lab: Our research desk audits 6,255 human trials from NEJM, The Lancet, JAMA, and NCBI PubMed—reporting true Absolute Risk Reduction (ARR) and sample sizes (N) without pharma spin.
Reset
1. Major Clinical Breakthroughs & Deep-Dive Study Breakdowns (2 Guides)

Sleep, Brain & Mental Health: Landmark Study Breakdowns

Plain-English breakdowns of the most important human trials—showing actual benefit percentages (ARR/NNT), dosing rules, and who should be careful.

Double-Blind Placebo-Controlled Sleep & Glycine RCTs N = 620 Adults Across 3 Human Trials

Why Magnesium Glycinate Calms Racing 2:00 A.M. Thoughts Without Leaving You Groggy the Next Morning

Bottom-Line Trial Result: Sleep Onset Latency: -17.4 Minutes (p = 0.002) • Serum Cortisol: -18% vs. Placebo • Serum Melatonin: +34% (p < 0.01)

A clinical evidence breakdown of how elemental magnesium blocks excitatory NMDA glutamate receptors while its glycine amino acid carrier lowers core body temperature via the suprachiasmatic nucleus—plus real RCT numbers on sleep latency, cortisol, and supplement label math.

Supplement: Magnesium Glycinate Condition: Insomnia
8 Min Read • 1,380 Words Read Study Guide →
Optical PPG vs. 12-Lead Holter ECG Validation Trials N = 1,420 Wearable vs. ECG Recordings

Why Your Smartwatch "Readiness Score" & Heart Rate Variability (HRV) Can Mislead You: Optical PPG vs. Clinical ECG Data

Bottom-Line Trial Result: Nocturnal Resting rMSSD Correlation: r = 0.94–0.98 vs. Gold-Standard ECG • Daytime Motion Artifact Error: 22%–38% Packet Loss

Millions of adults wake up and let a wrist or finger wearable tell them how "recovered" they are based on overnight Heart Rate Variability (rMSSD). Yet clinical validation studies comparing green/infrared optical photoplethysmography (PPG) against gold-standard 12-lead Holter ECG (PMID: 40321810, PMID: 37687769, PMID: 28838896) expose critical blind spots: motion artifacts, premature beats, alcohol, and unvalidated proprietary "Readiness" algorithms.

Condition: Heart & Vascular Hub Supplement: Magnesium Glycinate
8 Min Read • ~1,280 Words Read Study Guide →
3. All Indexed Clinical Studies (673)

Sleep, Brain & Mental Health — Clinical Trials & Study Reports (673)

Page 1 of 23 • Sorted by Participant Sample Size (N)
Randomized Controlled Trial N = 2,047

Retatrutide in adults with obesity and type 2 diabetes (TRIUMPH-2): a double-blind, parallel-group, randomised, placebo-controlled, phase 3 trial.

Between July 11, 2023, and Nov 1, 2024, 2047 participants were screened, and 1152 (mean age 55&#xb7;1 years [SD 10&#xb7;8], 554 [48%] females and 598 [52%] males, and 672 [58%] of White ethnicity) were randomly assigned to retatrutide 4 mg (n=292), 9 mg (n=284), or 12 mg (n=287),

Lancet • 2026-11-06 Read Study
Meta-Analysis & Systematic Review N = 1,251

The Effects of Mind-Body Exercise on Cognitive Function and Peripheral Blood BDNF in Elderly People With Mild Cognitive Impairment (N = 1,251)

Mind-body exercise is beneficial for improving global cognitive function, verbal fluency, executive function, episodic memory, and short-term memory in older adults with MCI; however, evidence remains insufficient regarding its effects on processing speed and attention and peripheral blood BDNF levels.

Geriatrics & gerontology international • 2026-10-24 Read Study
Meta-Analysis N = 892

Meta-Analysis: Efficacy of cognitive behavioral therapy for anxiety and depression symptoms in Parkinson's disease patients (N = 892)

CBT produces significant, clinically meaningful reductions in anxiety and depressive symptoms in patients with Parkinson's disease. Despite substantial between-study heterogeneity and variations in intervention delivery, structured CBT should be recommended as an integral component of multidisciplinary PD care.

Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology • 2026-11-05 Read Study
4. Quick Guide • Never Get Fooled by a Headline Again

How to Read a Clinical Study in 30 Seconds

Read FDA Bioequivalence Guide →
1. Relative Risk (RRR) vs. Absolute Risk (ARR)

If a drug drops heart attack risk from 2.0% to 1.0%, headlines scream “50% Relative Risk Reduction!” The real Absolute Risk Reduction (ARR) is 1.0%—meaning 100 people must take the drug (NNT = 100) to prevent 1 event.

2. Double-Blind RCT vs. Observational Association

Food questionnaires and observational cohorts can only show correlation (often confounded by wealth or exercise). Only a Randomized Controlled Trial (RCT) can prove that a drug or supplement actually caused the outcome.

3. Statistical p-Value vs. Clinical Meaning

In a massive 10,000-person trial, a blood pressure drop of 0.8 mmHg can achieve p < 0.05 (statistically significant) while having zero meaningful benefit in your daily life. Always look at the actual effect size.

4. Surrogate Lab Markers vs. Hard Outcomes

Raising HDL cholesterol or tweaking a single lab biomarker does not automatically prevent strokes or extend lifespan. Prioritize trials that measure hard patient outcomes (survival, remission, sleep latency, or GI tolerability).

Evidence Methodology, PubMed Verification & YMYL Standards

Frequently Asked Questions About dotMD Clinical Trial Breakdowns

Why does dotMD report both Absolute Risk Reduction (ARR) and Relative Risk Reduction (RRR) on clinical trials?

Traditional health headlines often exaggerate findings by reporting only Relative Risk Reduction—for example, claiming a drug cuts risk by 50% when the event rate dropped from 2% to 1% (an Absolute Risk Reduction of just 1.0 percentage point, meaning 100 patients must take the drug for 1 person to benefit, or NNT = 100). On dotMD, every flagship study breakdown reports both Relative Risk and Absolute Risk alongside the exact sample size (N) and trial duration.

How does dotMD separate human randomized controlled trials (RCTs) from animal or observational studies?

Every study on dotMD displays its exact Study Design Tier at the top of the card (Phase 3 Randomized Trial, Randomized Controlled Trial, Meta-Analysis & Systematic Review, Multi-Trial Clinical Evidence Synthesis, Journal Watch Cohort, or FDA Safety Alert) along with the human participant count (N). Preclinical mouse or cell-culture data is never presented as human clinical proof.

Why did dotMD replace synthetic "Study Rigor Scores" with primary PubMed PMIDs and trial metadata?

Arbitrary 0-to-100 rigor scores obscure what actually makes a study trustworthy. Instead of synthetic scores, dotMD surfaces the verifiable primary evidence signals: exact NCBI PubMed IDs (PMID), ClinicalTrials.gov registration numbers (NCT), double-blind vs. crossover design, sample size (N), p-values / Hazard Ratios, and study limitations.

How do dotMD Research Breakdowns connect to Conditions, Medications, Supplements, and Specialist Doctors?

Medical research is only useful if you can act on it safely with your clinician. Every flagship research synthesis links directly to the parent Condition diagnostic cutoff guide, the Medication FDA DailyMed & CMS NADAC wholesale price ledger, the Supplement elemental weight decoder, and our High-CPT-Volume Specialist Directory.